Myriad Genetics Stock Market Value

MYGN Stock  USD 18.63  0.03  0.16%   
Myriad Genetics' market value is the price at which a share of Myriad Genetics trades on a public exchange. It measures the collective expectations of Myriad Genetics investors about its performance. Myriad Genetics is selling at 18.63 as of the 25th of April 2024; that is 0.16 percent increase since the beginning of the trading day. The stock's open price was 18.6.
With this module, you can estimate the performance of a buy and hold strategy of Myriad Genetics and determine expected loss or profit from investing in Myriad Genetics over a given investment horizon. Check out Myriad Genetics Correlation, Myriad Genetics Volatility and Myriad Genetics Alpha and Beta module to complement your research on Myriad Genetics.
To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.
Symbol

Myriad Genetics Price To Book Ratio

Is Myriad Genetics' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Myriad Genetics. If investors know Myriad will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Myriad Genetics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share
(3.18)
Revenue Per Share
9.097
Quarterly Revenue Growth
0.106
Return On Assets
(0.07)
Return On Equity
(0.32)
The market value of Myriad Genetics is measured differently than its book value, which is the value of Myriad that is recorded on the company's balance sheet. Investors also form their own opinion of Myriad Genetics' value that differs from its market value or its book value, called intrinsic value, which is Myriad Genetics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Myriad Genetics' market value can be influenced by many factors that don't directly affect Myriad Genetics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Myriad Genetics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Myriad Genetics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Myriad Genetics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.

Myriad Genetics 'What if' Analysis

In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Myriad Genetics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Myriad Genetics.
0.00
03/26/2024
No Change 0.00  0.0 
In 30 days
04/25/2024
0.00
If you would invest  0.00  in Myriad Genetics on March 26, 2024 and sell it all today you would earn a total of 0.00 from holding Myriad Genetics or generate 0.0% return on investment in Myriad Genetics over 30 days. Myriad Genetics is related to or competes with Olink Holding, Sotera Health, RadNet, BiodesixInc, Castle Biosciences, Prenetics Global, and IQVIA Holdings. Myriad Genetics, Inc., a genetic testing and precision medicine company, develops and commercializes genetic tests in th... More

Myriad Genetics Upside/Downside Indicators

Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Myriad Genetics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Myriad Genetics upside and downside potential and time the market with a certain degree of confidence.

Myriad Genetics Market Risk Indicators

Today, many novice investors tend to focus exclusively on investment returns with little concern for Myriad Genetics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Myriad Genetics' standard deviation. In reality, there are many statistical measures that can use Myriad Genetics historical prices to predict the future Myriad Genetics' volatility.
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Myriad Genetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Hype
Prediction
LowEstimatedHigh
15.8018.6721.54
Details
Intrinsic
Valuation
LowRealHigh
17.4120.2823.15
Details
Naive
Forecast
LowNextHigh
15.0217.8920.76
Details
12 Analysts
Consensus
LowTargetHigh
18.8620.7223.00
Details
Please note, it is not enough to conduct a financial or market analysis of a single entity such as Myriad Genetics. Your research has to be compared to or analyzed against Myriad Genetics' peers to derive any actionable benefits. When done correctly, Myriad Genetics' competitive analysis will give you plenty of quantitative and qualitative data to validate your investment decisions or develop an entirely new strategy toward taking a position in Myriad Genetics.

Myriad Genetics Backtested Returns

Myriad Genetics has Sharpe Ratio of -0.0839, which conveys that the firm had a -0.0839% return per unit of risk over the last 3 months. Myriad Genetics exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Myriad Genetics' Risk Adjusted Performance of (0.01), mean deviation of 1.97, and Standard Deviation of 2.9 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 2.39, which conveys a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Myriad Genetics will likely underperform. Myriad Genetics has an expected return of -0.24%. Please make sure to verify Myriad Genetics treynor ratio, kurtosis, as well as the relationship between the Kurtosis and day typical price , to decide if Myriad Genetics performance from the past will be repeated at some point in the near future.

Auto-correlation

    
  0.80  

Very good predictability

Myriad Genetics has very good predictability. Overlapping area represents the amount of predictability between Myriad Genetics time series from 26th of March 2024 to 10th of April 2024 and 10th of April 2024 to 25th of April 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Myriad Genetics price movement. The serial correlation of 0.8 indicates that around 80.0% of current Myriad Genetics price fluctuation can be explain by its past prices.
Correlation Coefficient0.8
Spearman Rank Test0.59
Residual Average0.0
Price Variance0.48

Myriad Genetics lagged returns against current returns

Autocorrelation, which is Myriad Genetics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Myriad Genetics' stock expected returns. We can calculate the autocorrelation of Myriad Genetics returns to help us make a trade decision. For example, suppose you find that Myriad Genetics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
   Current and Lagged Values   
       Timeline  

Myriad Genetics regressed lagged prices vs. current prices

Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Myriad Genetics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Myriad Genetics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Myriad Genetics stock over time.
   Current vs Lagged Prices   
       Timeline  

Myriad Genetics Lagged Returns

When evaluating Myriad Genetics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Myriad Genetics stock have on its future price. Myriad Genetics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Myriad Genetics autocorrelation shows the relationship between Myriad Genetics stock current value and its past values and can show if there is a momentum factor associated with investing in Myriad Genetics.
   Regressed Prices   
       Timeline  

Myriad Genetics Investors Sentiment

The influence of Myriad Genetics' investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Myriad. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Myriad Genetics' public news can be used to forecast risks associated with an investment in Myriad. The trend in average sentiment can be used to explain how an investor holding Myriad can time the market purely based on public headlines and social activities around Myriad Genetics. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Myriad Genetics' market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Myriad Genetics' and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Myriad Genetics' news discussions. The higher the estimated score, the more favorable is the investor's outlook on Myriad Genetics.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Myriad Genetics in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Myriad Genetics' short interest history, or implied volatility extrapolated from Myriad Genetics options trading.

Building efficient market-beating portfolios requires time, education, and a lot of computing power!

The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.

Try AI Portfolio Architect
When determining whether Myriad Genetics offers a strong return on investment in its stock, a comprehensive analysis is essential. The process typically begins with a thorough review of Myriad Genetics' financial statements, including income statements, balance sheets, and cash flow statements, to assess its financial health. Key financial ratios are used to gauge profitability, efficiency, and growth potential of Myriad Genetics Stock. Outlined below are crucial reports that will aid in making a well-informed decision on Myriad Genetics Stock:
Check out Myriad Genetics Correlation, Myriad Genetics Volatility and Myriad Genetics Alpha and Beta module to complement your research on Myriad Genetics.
To learn how to invest in Myriad Stock, please use our How to Invest in Myriad Genetics guide.
Note that the Myriad Genetics information on this page should be used as a complementary analysis to other Myriad Genetics' statistical models used to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Sign In To Macroaxis module to sign in to explore Macroaxis' wealth optimization platform and fintech modules.

Complementary Tools for Myriad Stock analysis

When running Myriad Genetics' price analysis, check to measure Myriad Genetics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Myriad Genetics is operating at the current time. Most of Myriad Genetics' value examination focuses on studying past and present price action to predict the probability of Myriad Genetics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Myriad Genetics' price. Additionally, you may evaluate how the addition of Myriad Genetics to your portfolios can decrease your overall portfolio volatility.
Portfolio Rebalancing
Analyze risk-adjusted returns against different time horizons to find asset-allocation targets
My Watchlist Analysis
Analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Technical Analysis
Check basic technical indicators and analysis based on most latest market data
Latest Portfolios
Quick portfolio dashboard that showcases your latest portfolios
Price Transformation
Use Price Transformation models to analyze the depth of different equity instruments across global markets
Myriad Genetics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
A focus of Myriad Genetics technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Myriad Genetics trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions. More Info...